IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 155 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $873,000 | -15.3% | 18,822 | -39.9% | 0.00% | -33.3% |
| Q3 2020 | $1,031,000 | -44.5% | 31,307 | -53.7% | 0.00% | -50.0% |
| Q2 2020 | $1,856,000 | +34.7% | 67,602 | +47.0% | 0.01% | +100.0% |
| Q1 2020 | $1,378,000 | +10.6% | 46,000 | +2.2% | 0.00% | -40.0% |
| Q4 2019 | $1,246,000 | -22.2% | 45,000 | -48.9% | 0.01% | -16.7% |
| Q3 2019 | $1,602,000 | -37.8% | 88,000 | -16.2% | 0.01% | -40.0% |
| Q2 2019 | $2,575,000 | +185.2% | 105,000 | +10.5% | 0.01% | +150.0% |
| Q1 2019 | $903,000 | +785.3% | 95,000 | +1087.5% | 0.00% | – |
| Q2 2018 | $102,000 | – | 8,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |